Debate Series - Estro-events.org
Debate Series - Estro-events.org
Debate Series - Estro-events.org
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
sCiEnTiFiC proGrAMME<br />
Thursday 10 May 2012<br />
CliniCal inTERdiSCiPlinaRy PhySiCS RadiObiOlOgy RTT yOung<br />
Page 106 PROgRammE & ExhibiTiOn guidE • ESTRO 31<br />
abS. numbER<br />
PROFFERED PAPERS<br />
rAdiobioloGy 2: hEAd And nECK<br />
16:15 - 17:15 • Room 120-121<br />
ChaiR: P. Span (The Netherlands)<br />
CO-ChaiR: M. Pinkawa (Germany)<br />
16:15 > Head and neck cancer recurrence density in relation to<br />
FDG-PET and clinical IMRT target volumes<br />
A. Due (Denmark), I.R. Vogelius, M.C. Aznar, S.M. Bentzen,<br />
A.K. Berthelsen, S.S. Korreman, C.A. Kristensen, L. Specht OC-0148<br />
16:25 > HPV, smoking and RT-outcome in advanced OPC treated<br />
without chemotherapy - analysis of DAHANCA patients<br />
P. Lassen (Denmark), H. Primdahl, J. Johansen,<br />
C.A. Kristensen, E. Andersen, L.J. Andersen, J.F. Evensen,<br />
J. Overgaard OC-0149<br />
16:35 > Predictive value of CAIX expression and staining pattern<br />
in patients treated in the phase III randomised ARCON trial<br />
S. Rademakers (The Netherlands), I. Hoogsteen, P. Rijken,<br />
C. Terhaard, P. Doornaert, J. Langendijk, P. van den Ende,<br />
A. van der Kogel, J. Bussink, J. Kaanders OC-0150<br />
16:45 > P16 in head and neck cancer: a marker of impaired HIF1a<br />
function and decreased hypoxia tolerance?<br />
E. Van Limbergen (Belgium), R. Dok, E. Hauben, S. Nuyts OC-0151<br />
16:55 > Imaging of EGFR with USPECT in head and neck cancer<br />
xenografts with 111-In-labeled Cetuximab-F(ab’)2<br />
L.K. van Dijk (The Netherlands), G.M. Franssen, H. Stegeman,<br />
W.J.G. Oyen, J.H.A.M. Kaanders, O.C. Boerman, J. Bussink OC-0152<br />
17:05 > EGFR-inhibition and radiotherapy in head and neck<br />
cancer xenografts: hypoxia, proliferation and tumor growth delay<br />
H. Stegeman (The Netherlands), J.H.A.M. Kaanders,<br />
A.J. van der Kogel, M. Iida, D.L. Wheeler, P.N. Span, J. Bussink OC-0153<br />
Thursday 10 May 2012<br />
abS. numbER<br />
DEBATE<br />
This hoUsE bEliEVEs ThAT dAily VEriFiCATion And iMAGE AnAlysis<br />
is solEly ThE rEsponsibiliTy oF ThE rAdiATion onColoGisT<br />
lEaRning ObJECTivES:<br />
1. Identifying the proposed dilemmas of responsibilities, when implementing (new)<br />
position verification procedures<br />
2. Insight in arguments around position verification responsibilities, including cost<br />
effectiveness<br />
16:15 - 17:15 • Room 118-119<br />
ChaiR: M. Mast (The Netherlands)<br />
CO-ChaiR: E. Lartigau (France)<br />
CO-ChaiR: R. Moeckli (Switzerland)<br />
16:15 > For the motion<br />
SPEaKER: J. Kuipers (The Netherlands) SP-0154<br />
16:35 > Against the motion<br />
SPEaKER: A. Osztavics (Austria) SP-0155<br />
POSTER DISCUSSION: 4<br />
lUnG And sTErEoTACTiC<br />
16:15 - 17:00 • Poster Area<br />
ChaiR: M. Scorsetti (Italy)<br />
CO-ChaiR: G. Kantor (France)<br />
> Stereotactic body radiotherapy using volumetric modulated<br />
arc therapy in lung metastatic patients<br />
P. Navarria (Italy), A.M. Ascolese, E. Clerici, S. Castiglioni,<br />
F. Alongi, A. Tozzi, S. Pentimalli, S. Arcangeli, P. Mancosu,<br />
M. Scorsetti Pd-0156<br />
> Dose coverage in image guided SBRT for NSCLC using Tomotherapy<br />
L. Kerkmeijer (The Netherlands), V. Althof, A. Minken,<br />
R. Steenberg, E. Vonk Pd-0157<br />
> Functional promoter rs2868371 variant of HSPB1 predicts<br />
lung cancer survival<br />
T. Xu (USA), Q.Y. Wei, J.L. Lopez Guerra, Y. Zhuang,<br />
L.E. Wang, R. Mohan, D. Gomez, S. Lin, H.H. Zhou, Z.X. Liao Pd-0158<br />
ESTRO 31 • PROgRammE & ExhibiTiOn guidE Page 107<br />
sCiEnTiFiC proGrAMME<br />
eSTRO 31
Change language